These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25912546)

  • 1. Dystonia in an adolescent on risperidone following the discontinuation of methylphenidate: a case report.
    Guler G; Yildirim V; Kutuk MO; Toros F
    Clin Psychopharmacol Neurosci; 2015 Apr; 13(1):115-7. PubMed ID: 25912546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.
    Scholle O; Banaschewski T; Enders D; Garbe E; Riedel O
    J Child Adolesc Psychopharmacol; 2018; 28(6):415-422. PubMed ID: 29768038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.
    Goez H; Back-Bennet O; Zelnik N
    J Child Neurol; 2007 May; 22(5):538-42. PubMed ID: 17690058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed - Results from a randomized, double-blind, placebo-controlled clinical trial.
    Jahangard L; Akbarian S; Haghighi M; Ahmadpanah M; Keshavarzi A; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    Psychiatry Res; 2017 May; 251():182-191. PubMed ID: 28213188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued.
    Keshen A; Carandang C
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):867-70. PubMed ID: 18315457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance.
    Stämpfli D; Weiler S; Burden AM
    Eur Child Adolesc Psychiatry; 2021 Jul; 30(7):1047-1058. PubMed ID: 32621088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate-risperidone combination in child psychiatry: A retrospective analysis of 44 cases.
    Javelot H; Glay-Ribau C; Ligier F; Weiner L; Didelot N; Messaoudi M; Socha M; Body-Lawson F; Kabuth B
    Ann Pharm Fr; 2014 May; 72(3):164-77. PubMed ID: 24780832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Methylphenidate on Emotional Dysregulation in Children With Attention-Deficit/Hyperactivity Disorder + Oppositional Defiant Disorder/Conduct Disorder.
    Kutlu A; Akyol Ardic U; Ercan ES
    J Clin Psychopharmacol; 2017 Apr; 37(2):220-225. PubMed ID: 28225747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study.
    Ricketts EJ; Sturm A; McMakin DL; McGuire JF; Tan PZ; Smalberg FB; McCracken JT; Colwell CS; Piacentini J
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):690-698. PubMed ID: 30388029
    [No Abstract]   [Full Text] [Related]  

  • 13. Telephone-assisted self-help for parents of children with attention-deficit/hyperactivity disorder who have residual functional impairment despite methylphenidate treatment: a randomized controlled trial.
    Dose C; Hautmann C; Buerger M; Schuermann S; Woitecki K; Doepfner M
    J Child Psychol Psychiatry; 2017 Jun; 58(6):682-690. PubMed ID: 27878809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY; Fu AT; Yeh CB
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P; Weizman A
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.
    Gadow KD; Nolan EE; Sverd J; Sprafkin J; Schneider J
    J Child Neurol; 2008 Sep; 23(9):981-90. PubMed ID: 18474932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study.
    Armenteros JL; Lewis JE; Davalos M
    J Am Acad Child Adolesc Psychiatry; 2007 May; 46(5):558-565. PubMed ID: 17450046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Unexpected Circumstance: Acute Dystonic Reaction in the Setting of Clozapine Administration.
    Kaplan AM; Pitts WB; Ahmed I
    J Pharm Pract; 2019 Feb; 32(1):103-105. PubMed ID: 29092658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.